Pharma Equity Group A/S Cl A (CO:PEG) — Stock Price

Dkr0.09 DKK
▲ 4.41% today

Pharma Equity Group A/S Cl A (CO:PEG) is currently trading at Dkr0.09 DKK, up 4.41% today. Over the past 52 weeks, shares have ranged between Dkr0.07 and Dkr0.15. This page tracks Pharma Equity Group A/S Cl A's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Pharma Equity Group A/S Cl A market capitalisation.

Pharma Equity Group A/S Cl A (PEG) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pharma Equity Group A/S Cl A's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pharma Equity Group A/S Cl A Income Statement — Revenue, Profit & Earnings by Year

Pharma Equity Group A/S Cl A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Dkr0.00 Dkr0.00 Dkr0.00 Dkr0.00 Dkr0.00
Cost of Revenue Dkr311.00K Dkr235.00K Dkr480.00K Dkr0.00
Gross Profit Dkr-311.00K Dkr-235.00K Dkr-480.00K Dkr0.00
Research & Development Dkr5.12 Million Dkr9.00 Million Dkr8.82 Million Dkr5.50K
SG&A Dkr12.05 Million Dkr12.29 Million Dkr11.81K Dkr1.98 Million Dkr1.44 Million
Total Operating Expenses Dkr24.98 Million Dkr21.05 Million Dkr24.81 Million Dkr-3.03 Million Dkr-4.91 Million
Operating Income Dkr-25.29 Million Dkr-21.29 Million Dkr-25.29 Million Dkr3.03 Million Dkr-1.44 Million
EBITDA Dkr-24.98 Million Dkr-21.04 Million Dkr-24.80 Million Dkr4.47 Million Dkr6.06 Million
EBIT Dkr-25.29 Million Dkr-21.27 Million Dkr-25.28 Million Dkr4.47 Million Dkr5.82 Million
Interest Expense Dkr2.65 Million Dkr4.96 Million Dkr1.56 Million Dkr996.00K Dkr665.00K
Income Before Tax Dkr-26.41 Million Dkr-26.24 Million Dkr-26.84 Million Dkr3.48 Million Dkr5.39 Million
Income Tax Expense Dkr-1.03 Million Dkr-1.81 Million Dkr-2.23 Million Dkr-7.30 Million Dkr-6.35 Million
Net Income Dkr-25.38 Million Dkr-24.42 Million Dkr-24.61 Million Dkr3.48 Million Dkr5.39 Million

Pharma Equity Group A/S Cl A Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pharma Equity Group A/S Cl A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Dkr38.90 Million Dkr65.61 Million Dkr67.74 Million Dkr71.07 Million Dkr63.65 Million
Total Current Assets Dkr38.26 Million Dkr65.33 Million Dkr67.23 Million Dkr71.07 Million Dkr145.00K
Cash & Equivalents
Short-term Investments
Net Receivables Dkr37.18 Million Dkr60.29 Million Dkr4.58 Million Dkr70.89 Million Dkr145.00K
Inventory Dkr1.00K Dkr1.59K
Property, Plant & Equipment
Goodwill
Total Liabilities Dkr13.43 Million Dkr16.73 Million Dkr42.40 Million Dkr25.03 Million Dkr21.08 Million
Total Current Liabilities Dkr8.83 Million Dkr8.63 Million Dkr34.33 Million Dkr25.03 Million Dkr14.50 Million
Long-term Debt Dkr4.18 Million Dkr8.10 Million Dkr7.84 Million Dkr0.00 Dkr6.58 Million
Net Debt Dkr7.56 Million Dkr9.50 Million Dkr25.99 Million Dkr22.66 Million Dkr18.93 Million
Total Stockholder Equity Dkr25.47 Million Dkr48.88 Million Dkr25.33 Million Dkr46.05 Million Dkr42.57 Million
Retained Earnings Dkr27.39 Million Dkr23.91 Million

Pharma Equity Group A/S Cl A Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pharma Equity Group A/S Cl A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Dkr-17.66 Million Dkr-22.86 Million Dkr-16.62 Million Dkr-2.87 Million Dkr-2.09 Million
Capital Expenditures Dkr17.66 Million Dkr0.00 Dkr73.00K Dkr0.00 Dkr0.00
Free Cash Flow Dkr-17.66 Million Dkr-22.86 Million Dkr-16.70 Million Dkr-2.87 Million Dkr-2.09 Million
Investing Cash Flow Dkr11.00K Dkr-73.00K
Financing Cash Flow Dkr13.91 Million Dkr22.86 Million Dkr17.06 Million Dkr3.06 Million Dkr2.09 Million
Dividends Paid
Stock-Based Compensation Dkr0.00 Dkr217.00
Depreciation Dkr311.00K Dkr235.00K Dkr480.00K Dkr539.00
Change in Cash Dkr-3.74 Million Dkr3.00K Dkr1.40 Million Dkr182.00K Dkr0.00

Pharma Equity Group A/S Cl A Earnings History — EPS Actual vs. Analyst Estimates

Track Pharma Equity Group A/S Cl A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 20, 2025 -0.02 0.00
Nov 15, 2024 -0.01 -0.01 +0.00%
Aug 16, 2024 -0.01 0.00
May 16, 2024 -0.01 -0.01 +0.00%
Mar 29, 2024 -0.01 0.00
Nov 16, 2023 0.00 0.00
Aug 16, 2023 0.00
May 11, 2023 -0.15